Search hospitals > Ontario > LONDON

Children's Hospital

Claim this profile
LONDON, Ontario N6A 5W9
Global Leader in Acute Lymphoblastic Leukemia
Global Leader in Cancer
Conducts research for Crohn's Disease
Conducts research for Childhood Leukemia
Conducts research for Ulcerative Colitis
158 reported clinical trials
19 medical researchers
Photo of Children's Hospital in LONDONPhoto of Children's Hospital in LONDONPhoto of Children's Hospital in LONDON

Summary

Children's Hospital is a medical facility located in LONDON, Ontario. This center is recognized for care of Acute Lymphoblastic Leukemia, Cancer, Crohn's Disease, Childhood Leukemia, Ulcerative Colitis and other specialties. Children's Hospital is involved with conducting 158 clinical trials across 352 conditions. There are 19 research doctors associated with this hospital, such as Shayna M. Zelcer, Terry Ponich, MD, FRCPC, Matthew Weir, MD, and Adam Power, MD.

Area of expertise

1Acute Lymphoblastic Leukemia
Global Leader
Children's Hospital has run 18 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:
Stage II
Stage IV
Stage III
2Cancer
Global Leader
Children's Hospital has run 16 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage I
Stage II

Top PIs

Clinical Trials running at Children's Hospital

Brain Tumor
Testicular cancer
Wilms Tumor
Neuroblastoma
Acute Lymphoblastic Leukemia
Crohn's Disease
Ovarian Carcinoma
Ovarian Tumors
Testicular Carcinoma
Ovarian Choriocarcinoma
Image of trial facility.

DAY101 vs. Chemotherapy

for Pediatric Brain Cancer

This trial is testing tovorafenib, a medication given alone, in children with a specific type of brain tumor. The drug works by blocking a protein that helps cancer cells grow.
Recruiting2 awards Phase 3
Image of trial facility.

Health Information Collection

for Childhood Cancer

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
Recruiting1 award N/A10 criteria
Image of trial facility.

Lower Radiotherapy Dose

for Brain Tumors

This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous system (CNS) germinomas. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Researchers want to see if lowering the dose of standard radiotherapy (RT) after chemotherapy can help get rid of CNS germinomas with fewer long-term side effects.
Recruiting1 award Phase 210 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Children's Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security